Flavonoid Hydrogel Enzymatic Cross-Linking for Sustained Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Flavonoids, particularly EGCG, have limited bioavailability and therapeutic efficacy due to rapid metabolism and poor absorption, making it difficult to achieve therapeutic levels through dietary intake, and their anti-cancer properties are hindered by pro-oxidant effects and poor tissue distribution.
Innovation Solution
Development of hydrogels comprising enzymatically cross-linked conjugates of hyaluronic acid and flavonoids, such as EGCG, using horseradish peroxidase and hydrogen peroxide, which enables cell adhesion and sustained delivery of flavonoids, allowing for targeted anti-cancer effects while minimizing pro-oxidant activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If high doses of EGCG are consumed through dietary intake, then therapeutic effects are achieved, but the required amount of food and beverage is impractically large
Solution Approach 1:
The patent uses a hydrogel matrix as an intermediary delivery system that encapsulates and releases EGCG in a controlled manner. This mediator enables therapeutic concentrations to be achieved through minimal intake, resolving the contradiction between achieving therapeutic levels and the practicality of dietary consumption.
Solution Approach 2:
The patent modifies the physical and chemical parameters of EGCG by incorporating it into a hydrogel matrix, changing its release profile and bioavailability. This parameter change allows therapeutic effects to be achieved at much lower consumption levels compared to direct dietary intake.
2Reliability
If flavonoids are ingested through diet, then antioxidant properties are provided, but pro-oxidant activity is generated making delivery less effective
Solution Approach 1:
The patent converts the pro-oxidant activity of flavonoids into a beneficial controlled release mechanism. The hydrogel matrix controls the oxidation process, transforming the potentially harmful pro-oxidant effect into a controlled therapeutic delivery system that maintains antioxidant properties while minimizing harmful effects.
3Reliability
If high molecular weight flavonoids are used, then enhanced physiological properties are achieved, but absorption and transport to tissues is prevented
Solution Approach 1:
The patent segments the high molecular weight flavonoid into a controlled release system within the hydrogel matrix. This segmentation allows the flavonoid to be delivered in manageable portions that can be absorbed and transported to target tissues, maintaining the beneficial physiological properties while overcoming the absorption barrier.
4Reliability
If flavonoids are delivered directly, then therapeutic effects are achieved, but bioavailability is limited due to rapid metabolism
Solution Approach 1:
The patent performs preliminary action by pre-incorporating flavonoids into the hydrogel matrix before administration. This preliminary preparation protects the flavonoid from rapid metabolism and extends its activity half-life, enabling sustained therapeutic effects rather than rapid clearance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogels effectively adhere cells, including cancer cells, and provide sustained release of flavonoids, enhancing their anti-cancer properties and bioavailability, allowing for therapeutic benefits while maintaining minimal cytotoxicity to non-cancer cells.
Implementation Method 1
using a sufficient amount of a peroxidase enzyme, including horseradish peroxidase, to induce, in the presence of a peroxide, for example hydrogen peroxide, sufficient enzymatic cross-linking in the hydrogel
Implementation Method 2
using a sufficient amount of a peroxidase enzyme, including horseradish peroxidase, to induce sufficient enzymatic cross-linking
Implementation Method 3
produce a hydrogel capable of adhesion of cells
Data Source
Figure 1
Figure 2a~2f
Figure 3a(i)~3a(v)
AI summary
There is provided methods for producing a hydrogel comprising conjugates of a hydrogel forming agent and a flavonoid including a method for producing a hydrogel that is capable of adhesion of cells and which comprises enzymatically cross-linked conjugates of a hydrogel forming agent and a flavonoid. There is also provided a method for producing a hydrogel comprising conjugates of a hydrogel forming agent and a flavonoid without the addition of an exogenous peroxide or peroxidase or without the addition of an exogenous peroxide. Hydrogels produced by such methods and methods of using the hydrogels are also described herein.